News search

    E.g., 06/04/2025
    E.g., 06/04/2025
    Dr. José María Mendiguren, Director de Servicios Médicos de Banco Santander, Leticia Fernández-Friera, cardióloga del CNIC y del Hospital Universitario HM Montepríncipe, y Dr. Valentín Fuster, Director del CNIC.
    Research
    26 Mar 2019
    JACC: Advanced imaging technology predicts cardiovascular risk from inflammation detected in arteries

    The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    Photo
    Research
    8 Jan 2019
    Circulation: Expression of a molecule in blood cells predicts atherosclerosis risk

    The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors
    Foto
    Research
    19 Nov 2018
    The CNIC Conference addresses the emerging concepts of cardiovascular biology

    The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

    About the CNIC
    1 Oct 2018
    CNIC researcher Guadalupe Sabio receives the IV AstraZeneca Foundation Jóvenes Investigadores prize

    The Fundación AstraZeneca young researcher awards were created to give scientists the opportunities they deserve
    Bertie Göttgens y Miguel Manzanares
    About the CNIC
    27 Jul 2018
    Bertie Göttgens: "Communication between basic and clinical research is complex "

    Dr. Göttgens gave the conference "Cellular States, Differentiation Trajectories and Regulatory Networks of Blood Cell Development" at the CNIC Seminar cycle, invited by Dr. Miguel Manzanares.
    About the CNIC
    23 Apr 2018
    A CNIC-coordinated international project is set to receive €1 million in funding over the next 3 years

    The project is coordinated by Dr. José Antonio Enríquez and will receive funding worth $1350000 (€1.100.062) over the next 3 years
    De izda. a dcha.: José Antonio Enriquez, María del Mar Muñoz, Fátima Sánchez-Cabo, Luis Jesús Jiménez-Borreguero, Rocío Nieto-Arellano, Andrés González-Guerra, Carlos Torroja, José María Castellanos, y Concepción Jiménez.
    Research
    3 Apr 2018
    Science Translational Medicine: CNIC scientists identify a promising target for the treatment of heart failure

    The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
    About the CNIC
    20 Dec 2017
    A new Project from CNIC that researches new treatments for Progeria, funded in the E-Rare 2017 call

    The project ‘Identifying new treatments for Hutchinson-Gilford progeria syndrome’ (HGPS) TREAT-HGPS, coordinated by Dr. Vicente Andrés will receive funding of 797,744 € over the next three years